Cargando…

Trimming the fat: is there a health economic case for the use of new lipid-lowering drugs in chronic kidney disease? A scoping review

BACKGROUND: Individuals with chronic kidney disease (CKD) are at a very high risk for atherosclerotic cardiovascular disease (ASCVD). New lipid-lowering agents offer hope of improved outcomes where traditional agents have been less efficacious, yet the cost of these agents needs consideration in thi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gallagher, Alexandra, Agresta, Blaise, Smyth, Brendan, Jardine, Meg, Ferro, Charles, Morton, Rachael L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	CKJ Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9155226/ https://www.ncbi.nlm.nih.gov/pubmed/35664276 http://dx.doi.org/10.1093/ckj/sfab288

Ejemplares similares

The new Clinical Kidney Journal, 4 years later
por: Ortiz, Alberto, et al.
Publicado: (2019)

Risk for subsequent hypertension and cardiovascular disease after living kidney donation: is it clinically relevant?
por: Ferro, Charles J, et al.
Publicado: (2021)

Citation classics: ranking of the top 100 most cited articles in nephrology
por: Montinaro, Vincenzo, et al.
Publicado: (2018)

Screening for occult coronary artery disease in potential kidney transplant recipients: time for reappraisal?
por: Ferro, Charles J, et al.
Publicado: (2021)

The complex interplay between kidney injury and inflammation
por: McWilliam, Stephen J, et al.
Publicado: (2020)

Mineralocorticoid receptor antagonist use in chronic kidney disease with type 2 diabetes: a clinical practice document by the European Renal Best Practice (ERBP) board of the European Renal Association (ERA)
por: Sarafidis, Pantelis, et al.
Publicado: (2023)

Assessment of hypertension in kidney transplantation by ambulatory blood pressure monitoring: a systematic review and meta-analysis
por: Pisano, Anna, et al.
Publicado: (2021)

Uric acid lowering for slowing CKD progression after the CKD-FIX trial: a solved question or still a dilemma?
por: Leoncini, Giovanna, et al.
Publicado: (2022)

Gluconeogenesis in the kidney: in health and in chronic kidney disease
por: Dalga, Delal, et al.
Publicado: (2023)

Fighting the unbearable lightness of neglecting kidney health: the decade of the kidney
por: Vanholder, Raymond, et al.
Publicado: (2021)

Genetic kidney diseases as an underrecognized cause of chronic kidney disease: the key role of international registry reports
por: Torra, Roser, et al.
Publicado: (2021)

Immunotherapy in oncology and the kidneys: a clinical review of the evaluation and management of kidney immune-related adverse events
por: Rao Ullur, Avinash, et al.
Publicado: (2023)

Dietary potassium and the kidney: lifesaving physiology
por: Wei, Kuang-Yu, et al.
Publicado: (2020)

Systematic reporting of medical kidney biopsies
por: Leh, Sabine, et al.
Publicado: (2021)

Cutaneous manifestations of acute kidney injury
por: Esson, Gavin A, et al.
Publicado: (2021)

Kidney–placenta crosstalk in health and disease
por: Cabarcas-Barbosa, Omar, et al.
Publicado: (2022)

Tirzepatide and prevention of chronic kidney disease
por: Bosch, Catalina, et al.
Publicado: (2022)

Chronic kidney disease in children: an update
por: Cirillo, Luigi, et al.
Publicado: (2023)

Diastolic function in chronic kidney disease
por: de Simone, Giovanni, et al.
Publicado: (2023)

Intravenous iron therapy and the cardiovascular system: risks and benefits
por: Del Vecchio, Lucia, et al.
Publicado: (2020)

Coronavirus disease 2019 in chronic kidney disease
por: D’Marco, Luis, et al.
Publicado: (2020)

Treatment of acute kidney injury in cancer patients
por: Braet, Pauline, et al.
Publicado: (2021)

Exercise training in patients after kidney transplantation
por: De Smet, Stefan, et al.
Publicado: (2021)

Anaplastic lymphoma kinase inhibitors and their effect on the kidney
por: Bonilla, Marco, et al.
Publicado: (2022)

Donor liquid biopsy and outcomes in kidney transplantation
por: Anfaiha-Sanchez, Miriam, et al.
Publicado: (2022)

Prior cancer history and suitability for kidney transplantation
por: Wong, Germaine, et al.
Publicado: (2023)

Impact of public restrictive measures on hypertension during the COVID-19 pandemic: existing evidence and long-term implications
por: Karagiannidis, Artemios G, et al.
Publicado: (2022)

Step-by-step guide to setting up a kidney replacement therapy registry: the challenge of a national kidney replacement therapy registry
por: Rosa-Diez, Guillermo, et al.
Publicado: (2021)

Kidney transplantation and COVID-19 renal and patient prognosis
por: Toapanta, Néstor, et al.
Publicado: (2021)

Pathology of COVID-19-associated acute kidney injury
por: Sharma, Purva, et al.
Publicado: (2021)

Assessment of kidney function: clinical indications for measured GFR
por: Ebert, Natalie, et al.
Publicado: (2021)

Fiber intake and health in people with chronic kidney disease
por: Su, Guobin, et al.
Publicado: (2021)

Epidemiology and burden of chronic kidney disease-associated pruritus
por: Kim, Dana, et al.
Publicado: (2021)

Unravelling the pathophysiology of chronic kidney disease-associated pruritus
por: Schricker, Severin, et al.
Publicado: (2021)

Preventive strategies for acute kidney injury in cancer patients
por: Cosmai, Laura, et al.
Publicado: (2020)

Deprivation and chronic kidney disease—a review of the evidence
por: Grant, Christopher H, et al.
Publicado: (2023)

Ultraprocessed foods and chronic kidney disease—double trouble
por: Avesani, Carla Maria, et al.
Publicado: (2023)

Update on persistent acute kidney injury in critical illnesses
por: Samoni, Sara, et al.
Publicado: (2023)

Acute kidney injury pathology and pathophysiology: a retrospective review
por: Gaut, Joseph P, et al.
Publicado: (2020)

How to manage cigarette smoking in kidney transplant candidates and recipients?
por: Devresse, Arnaud, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ro19dkvhdtomi8vdhgv0q80v9p